Cargando…

EUPATI Guidance for Patient Involvement in Medicines Research and Development (R&D); Guidance for Pharmaceutical Industry-Led Medicines R&D

The importance and merits of greater patient involvement in medicines research and development (R&D) are commonly acknowledged and are thought to offer benefits for all involved parties. It helps to improve discovery, development, and evaluation of new effective medicines, based on the collabora...

Descripción completa

Detalles Bibliográficos
Autores principales:	Warner, Kay, See, Wolf, Haerry, David, Klingmann, Ingrid, Hunter, Amy, May, Matthew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6190844/ https://www.ncbi.nlm.nih.gov/pubmed/30356834 http://dx.doi.org/10.3389/fmed.2018.00270

Ejemplares similares

EUPATI and Patients in Medicines Research and Development: Guidance for Patient Involvement in Regulatory Processes
por: Haerry, David, et al.
Publicado: (2018)

EUPATI Guidance for Patient Involvement in Medicines Research and Development: Health Technology Assessment
por: Hunter, Amy, et al.
Publicado: (2018)

EUPATI and Patients in Medicines Research and Development: Guidance for Patient Involvement in Ethical Review of Clinical Trials
por: Klingmann, Ingrid, et al.
Publicado: (2018)

The Role of EUPATI CH in Promoting Patient Involvement in Clinical Research: A Multi-Stakeholder Research Project
por: Sessa, Cristiana, et al.
Publicado: (2021)

Improving Patient Involvement in the Lifecycle of Medicines: Insights From the EUPATI BE Survey
por: Grine, Lynda, et al.
Publicado: (2020)

The Specialist in Medicines Development (SMD) as a Vocational Program in Pharmaceutical Medicine: The Japanese and Italian Experience
por: Criscuolo, Domenico, et al.
Publicado: (2020)

The FDA guidance for industry on PROs: the point of view of a pharmaceutical company
por: Arpinelli, Fabio, et al.
Publicado: (2006)

Precision medicine: In need of guidance and surveillance
por: Lin, Jian-Zhen, et al.
Publicado: (2017)

Artificial intelligence and guidance of medicine in the bubble
por: Akbar, Asma, et al.
Publicado: (2021)

3D Bioprinting at the Frontier of Regenerative Medicine, Pharmaceutical, and Food Industries
por: Ramadan, Qasem, et al.
Publicado: (2021)

Comparison of external R&D and internal R&D: Based on the perspective of S&T development of China’s pharmaceutical manufacturing industry
por: Wu, Di, et al.
Publicado: (2022)

PLoS Medicine and the Pharmaceutical Industry
Publicado: (2006)

Defining the Path Forward: Guidance for Laboratory Medicine Guidelines
por: Kahn, Stephen E., et al.
Publicado: (2015)

Guidance for Safety and Dosing of Medicines in Patients With Cirrhosis Is Available
por: Weersink, Rianne A., et al.
Publicado: (2019)

COVID-19 pandemic: guidance for nuclear medicine departments
por: Paez, D., et al.
Publicado: (2020)

Exercise as medicine: Providing practitioner guidance on exercise prescription
por: Kyei-Frimpong, Jamie, et al.
Publicado: (2021)

Functional micro/nanobubbles for ultrasound medicine and visualizable guidance
por: Zhang, Chen, et al.
Publicado: (2021)

Guidance for the Harmonisation and Improvement of Economic Evaluations of Personalised Medicine
por: Vellekoop, Heleen, et al.
Publicado: (2021)

Public reporting on pharmaceutical industry-led access programs: alignment with the WHO medicine programs evaluation checklist
por: Umeh, Chukwuemeka A., et al.
Publicado: (2020)

Evaluation of 3D ultrasound for image guidance
por: Iommi, David, et al.
Publicado: (2020)

Key Factors to Improve Pharmaceutical Industry's R&D Productivity: A Case Study of Iranian Pharmaceutical Holding
por: Shabani, Atefeh, et al.
Publicado: (2022)

Public funding and private investment for R&D: a survey in China’s pharmaceutical industry
por: Qiu, Lan, et al.
Publicado: (2014)

Common Industry Practices and OIG Compliance Guidance
por: Tichon, Michael
Publicado: (2003)

Better Reporting, Better Research: Guidelines and Guidance in PLoS Medicine
Publicado: (2008)

Pharmacogenetic guidance: individualized medicine promotes enhanced pain outcomes
por: Dragic, Lisa Lynn, et al.
Publicado: (2017)

Quality of medicines in resource-limited settings: need for ethical guidance
por: Ravinetto, Raffaella, et al.
Publicado: (2018)

Interventional Procedures in Superficial Lesions: The Value of 2D with Additional Coronal Reformatted 4D Ultrasonography Guidance
por: Chang, Cheng-Yen, et al.
Publicado: (2006)

Evolution of the Development of Core Competencies in Pharmaceutical Medicine and Their Potential Use in Education and Training
por: Stonier, Peter D., et al.
Publicado: (2020)

Lewis Paul D: R for Medicine and Biology
por: Moore, G William
Publicado: (2010)

NICE guidance: a comparative study of the introduction of the single technology appraisal process and comparison with guidance from Scottish Medicines Consortium
por: Ford, John A, et al.
Publicado: (2012)

R&D Implementation in a Department of Laboratory Medicine and Pathology: A Systematic Review Based on Pharmaceutical Companies
por: Feulefack, Joseph, et al.
Publicado: (2015)

Big Data in Pharmaceutical R&D: Creating a Sustainable R&D Engine
por: Tormay, Peter
Publicado: (2015)

Precision medicine: an approach to R&D for delivering superior medicines to patients
por: Dolsten, Mikael, et al.
Publicado: (2012)

Model code of safety regulations for industrial establishments for the guidance of governments and industry
por: International Labour Office. Geneva
Publicado: (1954)

COVID-19 and dental sleep medicine: risks, precautions and patient guidance
por: Cunha, Thays Crosara Abrahão, et al.
Publicado: (2020)

Genomic and Phenotypic Biomarkers for Precision Medicine Guidance in Advanced Prostate Cancer
por: Davoudi, Fatemeh, et al.
Publicado: (2023)

Editorial: The European Patients Academy on Therapeutic Innovation (EUPATI) Guidelines on Patient Involvement in Research and Development
por: Spindler, Per, et al.
Publicado: (2018)

Innovation and Access to Medicines for Neglected Populations: Could a Treaty Address a Broken Pharmaceutical R&D System?
por: Moon, Suerie, et al.
Publicado: (2012)

Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance
Publicado: (2006)

Report of the AAPS Guidance Forum on the FDA Draft Guidance for Industry: “Drug Products, Including Biological Products, that Contain Nanomaterials”
por: de Vlieger, Jon S. B., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2j8e8c94g6v7frqvtcuo8c8m8f